Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 9,885,449 | 8,020,136 | -1,865,313 | $131.48M | $227.69M | 21.01% | +$96.22M |
| Kymera Therapeutics, Inc.(KYMR) | 5,858,262 | 5,377,362 | -480,900 | $149.15M | $216.17M | 19.95% | +$67.02M |
| Disc Medicine, Inc.(IRON) | 2,555,172 | 2,287,233 | -267,939 | $147.59M | $142.40M | 13.14% | -$5.18M |
| Day One Biopharmaceuticals, Inc. COM | 7,608,394 | 6,430,257 | -1,178,137 | $111.08M | $106.23M | 9.80% | -$4.85M |
| Third Harmonic Bio, Inc. | 10,907,859 | 10,907,859 | 0 | $119.66M | $102.97M | 9.50% | -$16.69M |
| Korro Bio, Inc.(KRRO) | 1,119,292 | 1,119,292 | 0 | $53.65M | $100.74M | 9.30% | +$47.09M |
| Aerovate Therapeutics, Inc. | 2,039,249 | 2,039,249 | 0 | $46.15M | $60.30M | 5.57% | +$14.15M |
| Q32 Bio Inc.(QTTB) | 0 | 2,092,106 | +2,092,106 | $0 | $35.65M | 3.29% | +$35.65M |
| Generation Bio, Co. | 8,279,484 | 8,279,484 | 0 | $13.66M | $33.70M | 3.11% | +$20.04M |
| Vigil Neuroscience, Inc. | 5,836,874 | 5,836,874 | 0 | $19.73M | $19.90M | 1.84% | +$175.1K |
| Replimune Group, Inc.(REPL) | 2,098,300 | 2,098,300 | 0 | $17.69M | $17.14M | 1.58% | -$545.6K |
| Ikena Oncology, Inc. | 5,018,178 | 5,018,178 | 0 | $9.89M | $7.13M | 0.66% | -$2.76M |
| AvroBio, Inc. | 4,541,381 | 4,541,381 | 0 | $6.18M | $5.81M | 0.54% | -$363.3K |
| Dianthus Therapeutics, Inc.(DNTH) | 236,979 | 186,979 | -50,000 | $2.46M | $5.61M | 0.52% | +$3.14M |
| Xilio Therapeutics, Inc.(XLO) | 2,759,344 | 992,912 | -1,766,432 | $1.52M | $1.07M | 0.10% | -$445.3K |
| Spero Therapeutics, Inc.(SPRO) | 1,013,438 | 607,613 | -405,825 | $1.49M | $1.05M | 0.10% | -$444.7K |
| Akero Therapeutics, Inc. | 359,251 | 0 | -359,251 | $8.39M | $0 | — | -$8.39M |